Throughout the years, this organisation has played a pivotal role in advancing Alzheimer’s research.
It has transitioned from providing some initial funding for Alzheimer’s research conducted by others, to actively conducting Alzheimer’s research in state-of-the-art facilities whilst collaborating broadly to deliver the best possible impact.
As we reflect on our journey, it’s noteworthy that our identity has evolved in tandem with our growth, leading to several name changes that mirror the dynamic nature of our commitment to progress in Alzheimer’s research.
While at UWA, Professor Martins first established a research laboratory at Hollywood Repatriation General Hospital in Nedlands, Perth.
The Sir James McCusker Alzheimer’s Disease Research Unit was established when Western Australian philanthropist Sir James McCusker provided funding through UWA for student research projects under Professor Martin’s supervision.
McCusker Foundation for Alzheimer’s Disease Research has its first board meeting.
The Foundation is renamed the McCusker Alzheimer’s Research Foundation.
Professor Martins becomes Professor of Ageing and Alzheimer’s at Edith Cowan University.
The Foundation purchases a facility at Hollywood Medical Centre to enable research expansion.
A clinical research facility was opened on Stirling Highway in Nedlands, WA with funding from Lotterywest.
The organisation is renamed to the Australian Alzheimer’s Research Foundation in order to embrace its position as a global leader in Alzheimer’s research.
Facilities and administration move to new facilities at the Ralph and Patricia Sarich Neuroscience Research Institute in Nedlands, Perth.
World-renowned actor Bryan Brown becomes an ambassador for the Foundation.
2024 – Alzheimer’s Research Australia: A new chapter
Our new name and recognition as a medical research institute recognise the breadth and depth of the activities we carry out and will enable us to better communicate our mission and ensure that our work resonates with our supporters and the global research community.
As a medical research institute specialising in Alzheimer’s and related dementias, we are driven by a deep commitment to changing the future of Alzheimer’s disease.
Timeline of Research Studies
Over the years, we have provided significant support to Alzheimer’s research, contributing to a deepening understanding of this disease, and leading to better outcomes for us all.
Global Alzheimer’s Research Breakthroughs
Significant advances have been made over many years by many research organisations around the world contributing to the understanding of Alzheimer’s.
Adjacent are some of the key breakthroughs achieved through the ongoing collaboration of the global research community.
The road to a cure
2022 Impact
Alzheimer’s Research Australia is a leading medical research institute specialising in Alzheimer’s disease and related dementias. Every year, countless individuals dedicate thousands of hours to research by participating in decades-long research studies, clinical trials, and fundraising efforts. Together, we are making a difference in the fight to create a world where Alzheimer’s is detected early, prevented effectively, and treated successfully.
The road to a cure
2022 Impact
Alzheimer’s Research Australia is a leading medical research institute specialising in Alzheimer’s disease and related dementias. Every year, countless individuals dedicate thousands of hours to research by participating in decades-long research studies, clinical trials, and fundraising efforts. Together, we are making a difference in the fight to create a world where Alzheimer’s is detected early, prevented effectively, and treated successfully.
01.
Global Partnerships
215 Collaborators
Our researchers are global partners undertaking research that involves collaborating with prestigious colleges, research groups, and universities from around the world. Together, we pool our expertise and resources to advance the fight against Alzheimer’s disease on a global scale.
02.
Research Facility Visits
3,000 Visits
In 2022, our state-of-the-art research facilities welcomed over 3,000 research participants and visitors. These individuals generously dedicated their time to Alzheimer’s research, contributing to the progress of our mission to better understand and combat this challenging disease.
03.
Pharmaceutical Trials
15 Trials
In 2022, we conducted 15 pharmaceutical trials aimed at exploring the efficacy of new treatments for Alzheimer’s disease. These trials are a crucial step in the search for effective therapies and interventions.
04.
Research Publications
39 Publications
In 2022, our researchers published 39 research papers, reviews, and articles. These contributions enrich the global body of knowledge on Alzheimer’s disease, sharing critical insights and discoveries with the scientific community and the public.
05.
International Collaborations
15 Countries
Our dedicated researchers collaborated with colleagues in 15 countries across the globe in 2022. This international collaboration enables us to leverage diverse perspectives and insights in the collective effort to combat Alzheimer’s disease.
06.
Brain Imaging
320 Brain Scans
Brain imaging is the gold standard for assessing Alzheimer’s disease. Our researchers conducted 320 brain scans, playing a vital role in advancing our understanding of the disease and supporting the development of potential treatments.
07.
Student Involvement
34 Students
In 2022, we nurtured the future of Alzheimer’s research by providing opportunities for 34 students to contribute to our mission. This group included 25 PhD candidates, who are poised to become the next generation of leaders in Alzheimer’s research, ensuring the continuity of our efforts.
About Us
Alzheimer’s Research Australia is one of the nation’s leading medical research institutes specialising in Alzheimer's disease and other dementias.
